NO871867D0 - Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser.

Info

Publication number
NO871867D0
NO871867D0 NO871867A NO871867A NO871867D0 NO 871867 D0 NO871867 D0 NO 871867D0 NO 871867 A NO871867 A NO 871867A NO 871867 A NO871867 A NO 871867A NO 871867 D0 NO871867 D0 NO 871867D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutic active
tricyclic compounds
heterocyclic condensed
Prior art date
Application number
NO871867A
Other languages
English (en)
Other versions
NO871867L (no
Inventor
Edward John Warawa
James Boniface Campbell
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of NO871867D0 publication Critical patent/NO871867D0/no
Publication of NO871867L publication Critical patent/NO871867L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO871867A 1986-05-06 1987-05-05 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser. NO871867L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868610980A GB8610980D0 (en) 1986-05-06 1986-05-06 Heterocyclic fused tricyclic compounds

Publications (2)

Publication Number Publication Date
NO871867D0 true NO871867D0 (no) 1987-05-05
NO871867L NO871867L (no) 1987-11-09

Family

ID=10597387

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871867A NO871867L (no) 1986-05-06 1987-05-05 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser.

Country Status (18)

Country Link
US (2) US4975435A (no)
EP (1) EP0245053B1 (no)
JP (1) JPS6327479A (no)
KR (1) KR910001283B1 (no)
AU (1) AU601975B2 (no)
DD (1) DD270913A5 (no)
DK (1) DK229987A (no)
FI (1) FI871985A (no)
GB (2) GB8610980D0 (no)
HU (1) HU196403B (no)
IL (1) IL82412A0 (no)
MW (1) MW3087A1 (no)
NO (1) NO871867L (no)
NZ (1) NZ220176A (no)
PT (1) PT84828B (no)
ZA (1) ZA873175B (no)
ZM (1) ZM3687A1 (no)
ZW (1) ZW8087A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179597B1 (en) * 1984-10-18 1993-02-03 Pfizer Inc. Spherically shaped precipitated calcium carbonate, its preparation and use
ES2056849T3 (es) * 1987-04-23 1994-10-16 Hoechst Roussel Pharma Heteroalquilen-quinolinaminas condensadas, un procedimiento y productos intermedios para su preparacion y su uso como medicamentos.
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
GB8828806D0 (en) * 1988-12-09 1989-01-18 Beecham Group Plc Novel compounds
JP2650533B2 (ja) * 1991-10-04 1997-09-03 王子製紙株式会社 嵩高なオフセット印刷用中質紙
US5243049A (en) * 1992-01-22 1993-09-07 Neurogen Corporation Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
US6541634B2 (en) 1999-02-26 2003-04-01 Pfizer Inc. Process for preparing growth hormone secretagogues
US20030220646A1 (en) * 2002-05-23 2003-11-27 Thelen Sarah L. Method and apparatus for reducing femoral fractures
US7442709B2 (en) * 2003-08-21 2008-10-28 Osi Pharmaceuticals, Inc. N3-substituted imidazopyridine c-Kit inhibitors
AU2004268949A1 (en) * 2003-08-21 2005-03-10 Osi Pharmaceuticals, Inc. N-substituted benzimidazolyl C-kit inhibitors
AP2006003553A0 (en) 2003-08-21 2006-04-30 Osi Pharm Inc N-substituted pyrazolyl-amidyl-benzimidazolyl C- kit inhibitors.
US7419995B2 (en) * 2004-12-01 2008-09-02 Osi Pharmaceuticals, Inc. N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole library
BRPI0620126A2 (pt) * 2005-12-20 2011-11-01 Astrazeneca Ab composto, composição farmacêutica, uso de um composto, método para modular a atividade de um receptor de gabaa, e, método sintético para fabricar um composto
US7465795B2 (en) * 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
AR067027A1 (es) * 2007-06-19 2009-09-30 Astrazeneca Ab Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a.
TW200911760A (en) * 2007-06-19 2009-03-16 Astrazeneca Ab Compounds and uses thereof
GB202016245D0 (en) * 2020-10-13 2020-11-25 Univ College Cardiff Consultants Ltd Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3647800A (en) * 1970-04-30 1972-03-07 American Home Prod 10-substituted - 1 2 3 4 - tetrahydrobenzo(b)(1 6)naphthyridines useful as cns depressants
BE790408A (fr) * 1971-10-22 1973-04-20 Rhone Poulenc Sa Nouveaux derives de la pyrrolo (3,4-b) pyridine, leur preparation et les compositions medicinales qui les
US4317915A (en) * 1976-08-23 1982-03-02 Hoffmann-La Roche Inc. Novel thiophene derivatives
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
US4511568A (en) * 1982-05-12 1985-04-16 Ici Americas Inc. CNS-Depressant pyrazolopyridines
GB8329531D0 (en) * 1983-11-04 1983-12-07 Ici America Inc Pyrazolopyridine cycloalkanones
GB8421116D0 (en) * 1984-08-20 1984-09-26 Ici America Inc Alkynyl derivatives
ATE63903T1 (de) * 1984-10-25 1991-06-15 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
US4631286A (en) * 1984-10-25 1986-12-23 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
FR2581382B1 (fr) * 1985-05-06 1987-06-26 Sanofi Sa Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes

Also Published As

Publication number Publication date
ZA873175B (en) 1988-02-24
EP0245053A1 (en) 1987-11-11
ZW8087A1 (en) 1988-12-14
DK229987D0 (da) 1987-05-05
NZ220176A (en) 1990-05-28
MW3087A1 (en) 1987-12-09
EP0245053B1 (en) 1992-11-25
PT84828A (en) 1987-06-01
US4975435A (en) 1990-12-04
KR910001283B1 (ko) 1991-02-28
HU196403B (en) 1988-11-28
NO871867L (no) 1987-11-09
FI871985A (fi) 1987-11-07
DK229987A (da) 1987-11-07
GB8610980D0 (en) 1986-06-11
FI871985A0 (fi) 1987-05-05
AU7241587A (en) 1987-11-12
KR870011136A (ko) 1987-12-21
JPS6327479A (ja) 1988-02-05
AU601975B2 (en) 1990-09-27
ZM3687A1 (en) 1988-09-30
GB8710384D0 (en) 1987-06-03
IL82412A0 (en) 1987-11-30
US5118688A (en) 1992-06-02
DD270913A5 (de) 1989-08-16
PT84828B (pt) 1989-12-29
HUT43849A (en) 1987-12-28

Similar Documents

Publication Publication Date Title
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO895086L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO870053D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive, nitrogenholdige, kondensert, aromatiske forbindelser.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO870075D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO172581C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske ketoner
NO893616D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser.
NO168174C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO884174D0 (no) Framgangsmaate for fremstilling av terapeutisk aktive tricykliske amidinoderivater.
NO871867D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO875488L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO890155L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO873680D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO884698D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO830900L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
NO865012L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater.
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO162617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske imidazolderivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.